Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy

被引:0
|
作者
Holgersson, Georg [1 ,2 ]
Bergstrtom, Stefan [1 ,2 ]
Liv, Per [1 ]
Nilsson, Jonas [1 ,2 ]
Edlund, Per [2 ]
Blomberg, Carl [1 ,2 ]
Nyman, Jan [3 ]
Friesland, Signe [4 ]
Ekman, Simon [5 ]
Asklund, Thomas [6 ]
Henriksson, Roger [6 ]
Bergqvist, Michael [1 ,2 ,6 ]
机构
[1] Uppsala Univ, Gavle Hosp, Ctr Res & Dev, Gavle, Sweden
[2] Gavle Cent Hosp, Dept Oncol, SE-80187 Gavle, Sweden
[3] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden
[4] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[5] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[6] Umea Univ Hosp, Dept Radiat Sci & Oncol, S-90185 Umea, Sweden
关键词
NSCLC; radiotherapy; toxicity; esophagitis; survival; RADIATION; CHEMOTHERAPY; CHEMORADIATION; CONCURRENT; THERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To elucidate the impact of different forms of radiation toxicities (esophagitis, radiation pneumonitis, mucositis and hoarseness), on the survival of patients treated with curatively intended radiotherapy for non-small cell lung cancer (NSCLC). Patients and Methods: Data were individually collected retrospectively for all patients diagnosed with NSCLC subjected to curatively intended radiotherapy (>= 50 Gy) in Sweden during the time period 1990 to 2000. Results: Esophagitis was the only radiation-induced toxicity with an impact on survival (hazard ratio=0.83, p=0.016). However, in a multivariate model, with clinical-and treatment-related factors taken into consideration, the impact of esophagitis on survival was no longer statistically significant (hazard ratio=0.88, p=0.17). Conclusion: The effect on survival seen in univariate analysis may be related to higher radiation dose and to the higher prevalence of chemotherapy in this group. The results do not suggest that the toxicities examined have any detrimental effect on overall survival.
引用
收藏
页码:5491 / 5497
页数:7
相关论文
共 50 条
  • [41] The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer
    Stinchcombe, Thomas E.
    Harper, Harry D.
    Hensing, Thomas A.
    Moore, Dominic T.
    Crane, Jeffery M.
    Atkins, James N.
    Willard, Ellen M.
    Detterbeck, Frank C.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 145 - 151
  • [42] The Survival Effect of Metformin on Non-Small Cell Lung Cancer Treated with Chemotherapy: A Systematic Review
    Li, Qin
    Fan, Qiao
    Wu, Ji
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023
  • [43] Palliative radiotherapy in patients with metastatic non-small cell lung cancer
    Nieder, Carsten
    Norum, Jan
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (01) : 51 - 53
  • [44] Survival analysis of patients with non-small cell lung cancer treated by surgery with curative intent
    Cruz, C.
    Afonso, M.
    Oliveiros, B.
    Pego, A.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2017, 23 (04) : 230 - 232
  • [45] Mediastinal lymphadenectomy improves survival in surgically treated patients with non-small cell lung cancer
    Davydov, M
    Volkov, S
    Polotsky, B
    Gerasimov, S
    Machaladze, Z
    Allahverdiyev, A
    Nojin, S
    Bouidenok, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 414 - 415
  • [46] Radiotherapy for non-small cell lung cancer in patients with compromised hearts
    Ampil, FL
    Milligan, S
    Mills, GM
    Caldito, G
    CHEST, 2005, 128 (04) : 312S - 312S
  • [47] PROGNOSTIC MODEL TO PREDICT SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER TREATED WITH GEFITINIB
    Park, M. J.
    Kim, H. S.
    Jun, H. J.
    Kim, K. H.
    Chang, M. H.
    Yi, S. Y.
    Lee, J.
    Park, K.
    Ahn, J. S.
    Ahn, M. J.
    ANNALS OF ONCOLOGY, 2008, 19 : 111 - 112
  • [48] External validation of the lung-molGPA to predict survival in patients treated with stereotactic radiotherapy for brain metastases of non-small cell lung cancer
    Crouzen, Jeroen A.
    Mast, Mirjam E.
    Hakstege, Martijn
    Broekman, Marike L. D.
    Baladi, Chaouki
    Mertens, Bart J. A.
    Tewarie, Rishi D. S. Nandoe
    Kerkhof, Melissa
    Vos, Maaike J.
    Maas, Klaar W.
    Souwer, Esteban T. D.
    Wiggenraad, Ruud G. J.
    van der Voort van Zyp, Noelle C. M. G.
    Kiderlen, Mandy
    Petoukhova, Anna L.
    Zindler, Jaap D.
    RADIOTHERAPY AND ONCOLOGY, 2024, 198
  • [49] Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
    Yan, Meng
    Zhang, Zhen
    Tian, Jia
    Yu, Jiaqi
    Dekker, Andre
    De Ruysscher, Dirk
    Wee, Leonard
    Zhao, Lujun
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [50] Effect of family history of cancer on postoperative survival in patients with non-small cell lung cancer
    Zhou, Jian
    Zheng, Quan
    Huang, Yuchen
    Lyu, Mengyuan
    Wang, Tengyong
    Wu, Dongsheng
    Liao, Hu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (08)